Document is current
Any future updates will be listed below
-
Authors
Truhn, Daniel
Geiger, Daniel
Siepmann, Robert
von der Stück, Marc Sebastian
Bressem, Keno Kyrill
Kather, Jakob Nikolas https://orcid.org/0000-0002-3730-5348
Kuhl, Christiane
Müller-Franzes, Gustav https://orcid.org/0000-0002-7413-2570
Nebelung, Sven https://orcid.org/0000-0002-5267-9962
- License Information
-
More Information
Article History
Received: 23 June 2025
Accepted: 14 April 2026
First Online: 21 April 2026
Competing interests
: D.T. received honoraria for lectures by Bayer, GE, and Philips and holds shares in StratifAI GmbH, Germany, and Synagen GmbH, Germany. J.N.K. declares consulting services for Bioptimus, France; Panakeia, UK; AstraZeneca, UK; and MultiplexDx, Slovakia. Furthermore, he holds shares in StratifAI, Germany, Synagen, Germany, and Ignition Lab, Germany; has received an institutional research grant by GSK; and has received honoraria by AstraZeneca, Bayer, Daiichi Sankyo, Eisai, Janssen, Merck, MSD, BMS, Roche, Pfizer, and Fresenius. K.K.B. received speaker fees from Canon Medical Systems Cooperations and GE Healthcare. All other authors declare no competing interests.
